Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Robustness testing of a tablet formulation using multivariate design.

Jon Gabrielsson1, Michael Sjöström, Nils-Olof Lindberg

  • 1Research Group for Chemometrics, Department of Chemistry, Umeå University, Umeå, Sweden.

Drug Development and Industrial Pharmacy
|March 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breakfast consumption and its relationship with diet quality and adherence to Mediterranean diet in European adolescents: the HELENA study.

European journal of clinical nutrition·2022
Same author

Social Environment and Food and Beverage Intake in European Adolescents: The Helena Study.

Journal of the American Nutrition Association·2022
Same author

Are Physical Activity and Sedentary Screen Time Levels Associated With Food Consumption in European Adolescents? The HELENA Study.

Journal of the American Nutrition Association·2022
Same author

A new measure of health motivation influencing food choices and its association with food intakes and nutritional biomarkers in European adolescents.

Public health nutrition·2020
Same author

Metabolomics analyses in non-diabetic middle-aged individuals reveal metabolites impacting early glucose disturbances and insulin sensitivity.

Metabolomics : Official journal of the Metabolomic Society·2020
Same author

Significant Changes in Metabolic Profiles after Intervention with Selenium and Coenzyme Q10 in an Elderly Population.

Biomolecules·2019
Same journal

Preparation and Characterisation of Pre-Nanoemulsions Encapsulating Multiple Oil-Soluble Active Substances.

Drug development and industrial pharmacy·2026
Same journal

Synergistic anticancer potential of andrographolide and paclitaxel: a dose-reduction strategy to minimize toxicity and enhance therapeutic efficacy.

Drug development and industrial pharmacy·2026
Same journal

Sustainable nanomaterial production from fruit waste: green synthesis of ZnO nanoparticles for antioxidant, antimicrobial, and therapeutic applications in wound healing and cancer therapy.

Drug development and industrial pharmacy·2026
Same journal

Biocompatible and bio-orthogonal surface engineering of inorganic self-assembled nanocrystals for precision drug targeting: a review.

Drug development and industrial pharmacy·2026
Same journal

Next-generation drug delivery for age-related macular degeneration: promise of controlled release formulations.

Drug development and industrial pharmacy·2026
Same journal

Design, optimization, and evaluation of ferulic acid-loaded cubosomal cream for enhanced topical delivery and anti-hyperpigmentation efficacy.

Drug development and industrial pharmacy·2026
See all related articles

This study assessed tablet formulation robustness against ingredient variations. Both tested tablet formulations demonstrated robustness under controlled conditions, ensuring consistent quality.

Area of Science:

  • Pharmaceutical Sciences
  • Drug Product Development

Background:

  • Tablet formulations require robust manufacturing processes to ensure consistent drug delivery.
  • Excipient and active pharmaceutical ingredient (API) variability can impact tablet performance.

Purpose of the Study:

  • To evaluate the robustness of two similar tablet formulations with varying API strengths.
  • To assess the impact of excipient and API batch-to-batch variation on tablet properties.

Main Methods:

  • Utilized 45 experiments to assess formulation robustness.
  • Employed principal component analysis (PCA) for excipient and API characterization.
  • Applied Plackett and Burman design to identify critical factors.
  • Regression analysis evaluated relationships between factors and responses (disintegration time, crushing strength).

Related Experiment Videos

Main Results:

  • Identified key variables influencing tablet properties through PCA and Plackett-Burman design.
  • Regression models established relationships between formulation factors and critical quality attributes.
  • Both tablet formulations exhibited robust performance despite ingredient variations.

Conclusions:

  • The evaluated tablet formulations are robust to normal batch-to-batch variations in excipients and API.
  • Controlled manufacturing processes can ensure consistent tablet quality for similar formulations.